CRVS vs. AVAH
CRVS (Corvus Pharmaceuticals, Inc.) and AVAH (Aveanna Healthcare Holdings Inc.) are both stocks. Both are in the Healthcare sector — CRVS in Biotechnology, AVAH in Medical Care Facilities. Over the past 5 years, CRVS returned 33.63%/yr vs -10.99%/yr for AVAH. At a 0.23 correlation, their price movements are largely independent.
Performance
CRVS vs. AVAH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRVS achieves a 54.94% return, which is significantly higher than AVAH's -13.22% return.
CRVS
- 1D
- 2.84%
- 1M
- -24.68%
- YTD
- 54.94%
- 6M
- 42.53%
- 1Y
- 181.37%
- 3Y*
- 53.32%
- 5Y*
- 33.63%
- 10Y*
- 0.06%
AVAH
- 1D
- 1.29%
- 1M
- 4.73%
- YTD
- -13.22%
- 6M
- -21.40%
- 1Y
- 39.57%
- 3Y*
- 72.97%
- 5Y*
- -10.99%
- 10Y*
- —
CRVS vs. AVAH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CRVS Corvus Pharmaceuticals, Inc. | 54.94% | 43.93% | 203.98% | 107.06% | -64.73% | -15.14% |
AVAH Aveanna Healthcare Holdings Inc. | -13.22% | 78.77% | 70.52% | 243.59% | -89.46% | -38.33% |
Correlation
The correlation between CRVS and AVAH is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Apr 28, 2021 | 0.23 |
Fundamentals
CRVS:
$1.07B
AVAH:
$1.57B
CRVS:
-$0.53
AVAH:
$1.20
CRVS:
4.46
AVAH:
6.56
CRVS:
$0.00
AVAH:
$2.52B
CRVS:
-$26.00K
AVAH:
$823.98M
CRVS:
-$47.43M
AVAH:
$306.37M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRVS vs. AVAH — Risk / Return Rank
CRVS
AVAH
CRVS vs. AVAH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corvus Pharmaceuticals, Inc. (CRVS) and Aveanna Healthcare Holdings Inc. (AVAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRVS | AVAH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.43 | ||
| Sortino ratioReturn per unit of downside risk | +2.61 | ||
| Omega ratioGain probability vs. loss probability | 1.48 | 1.20 | +0.28 |
| Calmar ratioReturn relative to maximum drawdown | 3.23 | 1.01 | +2.23 |
| Martin ratioReturn relative to average drawdown | 7.03 | 1.81 | +5.22 |
Loading charts...
Drawdowns
CRVS vs. AVAH - Drawdown Comparison
The maximum CRVS drawdown since its inception was -96.97%, roughly equal to the maximum AVAH drawdown of -94.76%. Use the drawdown chart below to compare losses from any high point for CRVS and AVAH.
Loading charts...
Drawdown Indicators
| CRVS | AVAH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.97% | -94.76% | -2.21% |
Max Drawdown (1Y)Largest decline over 1 year | -56.43% | -39.44% | -16.99% |
Max Drawdown (3Y)Largest decline over 3 years | -70.50% | -41.40% | -29.10% |
Max Drawdown (5Y)Largest decline over 5 years | -92.40% | -94.76% | +2.36% |
Max Drawdown (10Y)Largest decline over 10 years | -96.97% | — | — |
Current DrawdownCurrent decline from peak | -53.25% | -45.00% | -8.25% |
Average DrawdownAverage peak-to-trough decline | -69.28% | -63.57% | -5.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.91% | 21.95% | +3.96% |
Volatility
CRVS vs. AVAH - Volatility Comparison
Corvus Pharmaceuticals, Inc. (CRVS) has a higher volatility of 23.12% compared to Aveanna Healthcare Holdings Inc. (AVAH) at 15.70%. This indicates that CRVS's price experiences larger fluctuations and is considered to be riskier than AVAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRVS | AVAH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.12% | 15.70% | +7.42% |
Volatility (6M)Calculated over the trailing 6-month period | 111.88% | 32.16% | +79.72% |
Volatility (1Y)Calculated over the trailing 1-year period | 180.64% | 68.16% | +112.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 131.02% | 78.16% | +52.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 111.13% | 77.42% | +33.71% |
Dividends
CRVS vs. AVAH - Dividend Comparison
Neither CRVS nor AVAH has paid dividends to shareholders.
Financials
CRVS vs. AVAH - Financials Comparison
This section allows you to compare key financial metrics between Corvus Pharmaceuticals, Inc. and Aveanna Healthcare Holdings Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRVS and AVAH have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRVS has higher volatility (23.12%) compared to AVAH (15.70%). In terms of maximum drawdown, CRVS dropped -96.97% vs AVAH's -94.76%.
CRVS currently has the higher Sharpe Ratio (1.01 vs 0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRVS and AVAH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer